Shilpa Medicare Ltd (SHME)

Shilpa Medicare Ltd News & Analysis

• 

  Analog Devices earnings, Revenue beat in Q3

  Investing.com - Analog Devices (NASDAQ:ADI) reported on Wednesday third quarter {{erl-7869||earnings that beat analysts' forecasts and revenue that topped expectations. Analog Devices...

• 

  TJX earnings beat, Revenue misses in Q2

  Investing.com - TJX (NYSE:TJX) reported on Wednesday second quarter {{erl-8227||earnings that beat analysts' forecasts and revenue that fell short of expectations. TJX announced earnings...

• 

  Indian Finance Minister Issues Warnings Regarding Crypto

   The Indian finance minister suggested against using cryptocurrency.The law enforcement organization blocked the assets of two crypto exchanges.At a BJP Economic Cell event on Saturday,...

• 

  BRIEF-Shilpa Medicare Ltd Says Shilpa Pharma Filed Patent Infringement Lawsuit Against Novartis Pharmaceutical Corp

  April 26 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SHILPA MEDICARE LTD - SHILPA PHARMA FILED PATENT INFRINGEMENT LAWSUIT AGAINST NOVARTIS PHARMACEUTICAL CORP...

• 

  Indian shares rise 1% after central bank keeps rates steady

  By Sethuraman N RBENGALURU, April 7 (Reuters) - Indian shares and bonds rose on Wednesday after central bank kept interest rates at record lows to support the economy on the back of a record...

• 

  EXCLUSIVE-India's Shilpa Medicare can make 100-200 mln doses of COVID-19 vaccine, says exec

  (Adds details, background; updates shares)By Sachin RavikumarBENGALURU, April 7 (Reuters) - Indian drugmaker Shilpa Medicare Ltd SHME.NS has the capacity to manufacture 100-200 million...

• 

  EXCLUSIVE-India's Shilpa Medicare can make 100-200 mln doses of COVID-19 shot, says exec

  By Sachin RavikumarBENGALURU, April 7 (Reuters) - Indian drugmaker Shilpa Medicare Ltd SHME.NS has the production capacity to make 100-200 million doses of a recombinant vaccine for...

• 

  BRIEF-Shilpa Medicare Says Board Approved Sale Of Loba Feinchemie GMBH

  March 31 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SHILPA MEDICARE LTD - BOARD APPROVED SALE OF LOBA FEINCHEMIE GMBH* SHILPA MEDICARE LTD - DEAL FOR ABOUT EUR 3.3 MILLION...

• 

  BRIEF-Shilpa Medicare Launches Sunitinib Capsules Under Brand Name SUNISHIL In India

  Feb 15 (Reuters) - Shilpa Medicare Ltd SHME.NS :* LAUNCHES SUNITINIB CAPSULES UNDER BRAND NAME SUNISHIL IN INDIA...

• 

  BRIEF-Shilpa Medicare CFO Sushil Bajaj Resigns

  Jan 19 (Reuters) - Shilpa Medicare Ltd SHME.NS :* CFO SUSHIL BAJAJ RESIGNED

• 

  BRIEF-Shilpa Medicare To Set Up Unit In Malaysia

  Sept 18 (Reuters) - Shilpa Medicare Ltd SHME.NS :* TO ESTABLISH WHOLE OWNED SUBSIDIARY IN MALAYSIA...

• 

  BRIEF-Shilpa Medicare March Quarter Consol Profit Rises

  June 18 (Reuters) - Shilpa Medicare Ltd SHME.NS :* MARCH QUARTER CONSOL NET PROFIT 345.7 MILLION RUPEES VERSUS 238.8 MILLION RUPEES* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.2...

• 

  BRIEF-Shilpa Medicare- Approved To Acquire FTF Pharma Pvt Ltd

  June 16 (Reuters) - Shilpa Medicare Ltd SHME.NS :* APPROVED TO ACQUIRE FTF PHARMA PVT LTD* APPROVED TO BUY AUXILLA PHARMACEUTICALS AND RESEARCH LLP VIA UNIT* SHILPA MEDICARE LTD - GROSS...

• 

  BRIEF-India's Shilpa Medicare March-Qtr Consol Net Profit Rises

  June 15 (Reuters) - Shilpa Medicare Ltd SHME.NS :* MARCH-QUARTER CONSOL NET PROFIT 345.7 MILLION RUPEES VERSUS 238.8 MILLION RUPEES YEAR AGO* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS...

• 

  BRIEF-Shilpa Medicare Launches Indian Branded Generic Of Anti-Cancer Drug Ibrutinib

  May 28 (Reuters) - Shilpa Medicare Ltd SHME.NS :* LAUNCHES INDIAN BRANDED GENERIC OF ANTI-CANCER DRUG IBRUTINIB, WITH BRAND NAME IBRUSHIL* IBRUSHIL MONTHLY THERAPY COST WILL BE 34,920...

• 

  BRIEF-Shilpa Medicare -Approved Establishing Units In Canada And Spain

  May 5 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SHILPA MEDICARE LTD -APPROVED ESTABLISHING UNITS IN CANADA AND SPAIN...

• 

  BRIEF-Shilpa Medicare Gets UK MHRA Approval For Imatinib Oral Solution

  April 6 (Reuters) - Shilpa Medicare Ltd SHME.NS :* THROUGH UK UNIT KOANAA HEALTHCARE, GETS UK MHRA APPROVAL FOR IMATINIB ORAL SOLUTION* IMATINIB ORAL SOLUTION IS EXPECTED TO BE AVAILABLE...

• 

  BRIEF-India's Shilpa Medicare Declares Interim Dividend At 1.10 Rupees/Share For FY 2019-20

  March 6 (Reuters) - Shilpa Medicare Ltd SHME.NS :* DECLARED INTERIM DIVIDEND AT 1.10 RUPEES/SHARE FOR FY...

• 

  BRIEF-India's Shilpa Medicare Reports Higher Dec-Quarter Profit

  Feb 10 (Reuters) - Shilpa Medicare Ltd SHME.NS :* DEC-QUARTER CONSOL NET PROFIT 550.6 MILLION RUPEES VERSUS 124.7 MILLION RUPEES YEAR AGO* DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.37...

• 

  BRIEF-Shilpa Medicare Gets U.S FDA Tentative Approval For Its ANDA, Pirfenidone Tablets

  Jan 31 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SHILPA MEDICARE LTD SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION TENTATIVE APPROVAL FOR ITS ANDA, PIRFENIDONE TABLETS, 267 MG AND 801...

• 

  BRIEF-Shilpa Medicare Says Successful Closure Of Inspection, With Receipt Of EIR From FDA

  Dec 4 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SHILPA MEDICARE -SUCCESSFUL CLOSURE OF INSPECTION, WITH RECEIPT OF EIR FROM FDA FOR INSPECTION AT SITE LOCATED AT RAICHUR,...

• 

  BRIEF-India's Shilpa Medicare Sept Quarter Consol Net Profit Rises

  Nov 11 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SEPT QUARTER CONSOL NET PROFIT 507.8 MILLION RUPEES VERSUS 422.7 MILLION RUPEES YEAR AGO* SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 2.90...

• 

  BRIEF-Shilpa Medicare Gets USFDA Final Nod For Erlotinib Tablets

  Nov 6 (Reuters) - Shilpa Medicare Ltd SHME.NS :* GETS USFDA FINAL NOD FOR ITS ANDA, ERLOTINIB TABLETS, 25 MG, 100 MG, AND 150...

• 

  BRIEF-India's Shilpa Medicare Sets Final Dividend Of 1 Rupee Per Share

  Sept 23 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SAYS SETS FINAL DIVIDEND OF 1 RUPEE PER SHARE Further company coverage:...

• 

  BRIEF-India's Shilpa Medicare June-Qtr Consol Net Profit Drops

  Aug 13 (Reuters) - Shilpa Medicare Ltd SHME.NS :* JUNE QUARTER CONSOL NET PROFIT 157.4 MILLION RUPEES VERSUS 336.4 MILLION RUPEES YEAR AGO* JUNE QUARTER REVENUE FROM OPERATIONS 1.61...

• 

  BRIEF-Shilpa Medicare's Raichur Site Gets U.S. FDA Form 483 With 5 Observations

  July 29 (Reuters) - India's Shilpa Medicare Ltd SHME.NS :* RECEIVED FORM 483 WITH 5 OBSERVATIONS AFTER U.S. FDA AUDIT AT RAICHUR SITE; OBSERVATIONS "MOSTLY PROCEDURAL"...

• 

  BRIEF-Shilpa Medicare Gets USFDA Final Approval For Its ANDA, Docetaxel Injection

  May 17 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, DOCETAXEL INJECTION...

• 

  BRIEF-Shilpa Medicare Gets U.S. FDA Final Nod For ANDA, Zoledronic Acid Injection

  May 16 (Reuters) - Shilpa Medicare Ltd SHME.NS :* RECEIVED U.S. FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, ZOLEDRONIC ACID INJECTION, 4 MG/5 ML...

• 

  BRIEF-Shilpa Medicare Gets U.S. FDA Tentative Nod For ANDA, Bortezomid For Injection, 3.5Mg/Vial

  April 9 (Reuters) - Shilpa Medicare Ltd SHME.NS :* GETS U.S. FDA TENTATIVE APPROVAL FOR ITS ANDA, BORTEZOMID FOR INJECTION, 3.5MG/VIAL...

• 

  BRIEF-Shilpa Medicare Gets USFDA Approval For Its ANDA, Gemcitabine For Injection USP

  Feb 25 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SAYS GOT USFDA APPROVAL FOR ITS ANDA, GEMCITABINE FOR INJECTION USP, 200 MG/VIAL AND 1 G/VIAL* SHILPA MEDICARE-DRUG IS GENERIC EQUIVALENT...

• 

  BRIEF-India's Shilpa Medicare Dec-Qtr Net PAT Falls

  Feb 7 (Reuters) - Shilpa Medicare Ltd SHME.NS :* DEC QUARTER CONSOL NET PAT 124.7 MILLION RUPEES VERSUS 173 MILLION RUPEES YEAR AGO* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.73 BILLION...

• 

  BRIEF-Shilpa Medicare Gets U.S FDA Nod For ANDA Imatinib Mesylate Tablets

  Jan 18 (Reuters) - Shilpa Medicare Ltd SHME.NS :* SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION APPROVAL FOR ITS ANDA, IMATINIB MESYLATE TABLETS* SAYS DRUG USED IN TREATMENT OF LEUKEMIA...

• 

  BRIEF-Shilpa Medicare Gets USFDA Approval For ANDA Irinotecan HCL Injection USP Single Dose Vials

  Jan 1 (Reuters) - Shilpa Medicare Ltd SHME.NS : * GETS USFDA APPROVAL FOR ANDA IRINOTECAN HCL INJECTION USP SINGLE DOSE...

• 

  BRIEF-India's Shilpa Medicare's Dimethyl Fumarate Capsules Gets Tentative Approval By FDA

  Nov 16 (Reuters) - Shilpa Medicare Ltd SHME.NS : * CO'S ANDA FOR DIMETHYL FUMARATE DELAYED RELEASE CAPSULES 120 MG & 240 MG HAS BEEN GRANTED TENTATIVE APPROVAL BY FDA Source: https://...

• 

  BRIEF-Shilpa Medicare To Acquire 5.2 Pct Stake Of Prathijna Sustainable Solutions

  Nov 15 (Reuters) - Shilpa Medicare Ltd SHME.NS : * SAYS TO ACQUIRE 5.2 PERCENT STAKE OM PRATHIJNA SUSTAINABLE...

• 

  BRIEF-India's Shilpa Medicare Sept-Qtr Consol Net Profit Rises

  Nov 14 (Reuters) - Shilpa Medicare Ltd SHME.NS : * SEPT QUARTER CONSOL NET PROFIT 422.7 MILLION RUPEES VERSUS PROFIT 341.5 MILLION RUPEES YEAR AGO * SEPT QUARTER CONSOL REVENUE FROM...

• 

  BRIEF-Shilpa Medicare To Promote Unit Shilpa Pharma Inc, USA For Ops In U.S. And North America

  Aug 14 (Reuters) - Shilpa Medicare Ltd SHME.NS : * SAYS TO PROMOTE UNIT SHILPA PHARMA INC, USA FOR OPERATIONS IN U.S. AND NORTH AMERICAN...

• 

  BRIEF-India's Shilpa Medicare June-Qtr Profit Rises

  Aug 13 (Reuters) - Shilpa Medicare Ltd SHME.NS : * JUNE QUARTER PROFIT 427.1 MILLION RUPEES VERSUS 254.2 MILLION RUPEES YEAR AGO * JUNE QUARTER REVENUE FROM OPERATIONS 1.80 BILLION...

• 

  BRIEF-India's Shilpa Medicare Gets EIR From U.S FDA For Karnataka API Units

  July 11 (Reuters) - Shilpa Medicare Ltd SHME.NS : * GETS EIR FROM U.S FDA TO API MANUFACTURING FACILITIES AT RAICHUR, KARNATAKA * SAYS INSPECTION WAS CARRIED OUT BETWEEN JANUARY 16 TO...

• 

  BRIEF-India's Shilpa Medicare March Quarter Consol Profit Falls

  May 28 (Reuters) - Shilpa Medicare Ltd SHME.NS :* MARCH QUARTER CONSOL PROFIT 306.4 MILLION RUPEES VERSUS PROFIT 373.3 MILLION RUPEES YEAR AGO* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS...

• 

  BRIEF-Shilpa Medicare Gets EU-GMP Certification From AGES For 2 API Manufacturing Plants, Formulation Facility

  April 23 (Reuters) - Shilpa Medicare Ltd SHME.NS : * GOT EU-GMP CERTIFICATION FROM AUSTRIAN AGENCY AGES FOR 2 API MANUFACTURING PLANTS IN KARNATAKA,FORMULATION FACILITY IN TELANGANA *...

• 

  BRIEF-India's Shilpa Medicare Declared Interim Dividend Of 0.70 Rupees Per Shr

  Feb 22 (Reuters) - Shilpa Medicare Ltd SHME.NS : * DECLARED INTERIM DIVIDEND OF 0.70 RUPEES PER EQUITY...

• 

  BRIEF-India's Shilpa Medicare Dec-Qtr Consol Profit Falls

  Feb 13 (Reuters) - Shilpa Medicare Ltd SHME.NS : * DEC QUARTER CONSOL PROFIT 163.4 MILLION RUPEES VERSUS PROFIT OF 170.5 MILLION RUPEES YEAR AGO * DEC QUARTER CONSOL REVENUE FROM...